Integrative Analysis of Genetic Risk Factors for Acute Myeloid Leukemia Using Mendelian Randomization and Single‐Cell RNA Sequencing Validation
International Journal of Genomics · 2026-01 · 2026 (1)
DOI: 10.1155/ijog/5584620 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Genomics, online erschienen am 30.05.2026. Verfasst von Tian Xia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Zhanjiang Central People's Hospital, Zhanjiang, Guangdong, China. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy with complex genetic underpinnings. Understanding the causal relationships between genetic factors and AML risk is crucial for developing targeted therapeutic strategies.
Methods
We conducted a comprehensive Mendelian randomization (MR) analysis to evaluate causal effects of 10 genetic exposures on AML risk using multiple analytical methods including inverse‐variance weighted, weighted median, simple mode, weighted mode, and MR‐Egger regression. Single‐cell RNA sequencing analysis was performed to validate gene expression patterns and investigate cellular heterogeneity in AML. Quality control, clustering analysis, and cell type annotation were conducted to characterize the expression profiles of identified risk genes.
Results
MR analysis revealed heterogeneous causal effects across genetic exposures. Three genes demonstrated significant protective effects: COL11A2 (OR: 0.425–0.481), MTHFD1 (OR: 0.142–0.151), and SERPINA10 (OR: 0.426–0.560). Seven genes showed risk‐increasing effects: SPATA20 , PDE5A , ANXA11 , FUT10 , TXNL4B , RNASET2 , and TCL1A , with PDE5A showing the strongest risk association (OR > 8.0). Single‐cell analysis identified 17 distinct cell populations and 14 cell types, revealing cell‐specific expression patterns of these risk genes across different hematopoietic lineages.
Conclusions
This integrative approach provides robust evidence for causal relationships between specific genetic factors and AML risk, offering insights into disease mechanisms and potential therapeutic targets at the cellular level.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Zhanjiang Central People's Hospital, Zhanjiang, Guangdong, China.
ORCID-Profile: Tian Xia, Ruiting Wen, Guocai Wu, Yunguang Hong, Dasi Luo
Zitieren
APA
Xia, T., Wen, R., Wu, G., Hong, Y., & Luo, D. (2026). Integrative Analysis of Genetic Risk Factors for Acute Myeloid Leukemia Using Mendelian Randomization and Single‐Cell RNA Sequencing Validation. International Journal of Genomics, 2026(1). https://doi.org/10.1155/ijog/5584620
Vancouver
Xia T, Wen R, Wu G, Hong Y, Luo D. Integrative Analysis of Genetic Risk Factors for Acute Myeloid Leukemia Using Mendelian Randomization and Single‐Cell RNA Sequencing Validation. International Journal of Genomics. 2026;2026(1). doi:10.1155/ijog/5584620
BibTeX
@article{Xia2026,
author = {Xia, Tian and Wen, Ruiting and Wu, Guocai and Hong, Yunguang and Luo, Dasi},
title = {Integrative Analysis of Genetic Risk Factors for Acute Myeloid Leukemia Using Mendelian Randomization and Single‐Cell RNA Sequencing Validation},
journal = {International Journal of Genomics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijog/5584620}
}
EUVIMED